Logo image of DXYN

DIXIE GROUP INC (DXYN) Stock Fundamental Analysis

NASDAQ:DXYN - US2555191004 - Common Stock

0.5301 USD
-0.15 (-22.33%)
Last: 10/2/2024, 8:05:26 PM
0.5495 USD
+0.02 (+3.66%)
After Hours: 10/2/2024, 8:05:26 PM
Fundamental Rating

1

Overall DXYN gets a fundamental rating of 1 out of 10. We evaluated DXYN against 63 industry peers in the Household Durables industry. DXYN may be in some trouble as it scores bad on both profitability and health. DXYN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DXYN has reported negative net income.
DXYN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DXYN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DXYN reported negative operating cash flow in multiple years.
DXYN Yearly Net Income VS EBIT VS OCF VS FCFDXYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

1.2 Ratios

With a Return On Assets value of -0.57%, DXYN is not doing good in the industry: 68.25% of the companies in the same industry are doing better.
The Return On Equity of DXYN (-4.14%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA -0.57%
ROE -4.14%
ROIC N/A
ROA(3y)-6.01%
ROA(5y)-3.16%
ROE(3y)-39.43%
ROE(5y)-22.36%
ROIC(3y)N/A
ROIC(5y)N/A
DXYN Yearly ROA, ROE, ROICDXYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 26.51%, DXYN is in line with its industry, outperforming 52.38% of the companies in the same industry.
In the last couple of years the Gross Margin of DXYN has grown nicely.
DXYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y4.47%
DXYN Yearly Profit, Operating, Gross MarginsDXYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

3

2. Health

2.1 Basic Checks

DXYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
DXYN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DXYN has been reduced compared to 5 years ago.
The debt/assets ratio for DXYN has been reduced compared to a year ago.
DXYN Yearly Shares OutstandingDXYN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
DXYN Yearly Total Debt VS Total AssetsDXYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

DXYN has an Altman-Z score of 0.56. This is a bad value and indicates that DXYN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.56, DXYN is not doing good in the industry: 87.30% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.08 is on the high side and indicates that DXYN has dependencies on debt financing.
DXYN's Debt to Equity ratio of 3.08 is on the low side compared to the rest of the industry. DXYN is outperformed by 95.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.08
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC6.81%
DXYN Yearly LT Debt VS Equity VS FCFDXYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

DXYN has a Current Ratio of 2.57. This indicates that DXYN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DXYN (2.57) is comparable to the rest of the industry.
A Quick Ratio of 0.87 indicates that DXYN may have some problems paying its short term obligations.
DXYN has a worse Quick ratio (0.87) than 60.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 0.87
DXYN Yearly Current Assets VS Current LiabilitesDXYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

DXYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.35%, which is quite impressive.
Looking at the last year, DXYN shows a decrease in Revenue. The Revenue has decreased by -4.36% in the last year.
DXYN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.36% yearly.
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.36%
Revenue 1Y (TTM)-4.36%
Revenue growth 3Y3.27%
Revenue growth 5Y-7.36%
Sales Q2Q%-4.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DXYN Yearly Revenue VS EstimatesDXYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
DXYN Yearly EPS VS EstimatesDXYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2023 0 0.1 -0.1 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DXYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DXYN Price Earnings VS Forward Price EarningsDXYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXYN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.28
DXYN Per share dataDXYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DXYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIXIE GROUP INC

NASDAQ:DXYN (10/2/2024, 8:05:26 PM)

After market: 0.5495 +0.02 (+3.66%)

0.5301

-0.15 (-22.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-08 2024-08-08/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners20.31%
Inst Owner Change0%
Ins Owners10.24%
Ins Owner Change-1.8%
Market Cap8.15M
Analysts82.86
Price TargetN/A
Short Float %0.05%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA 13.28
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS17.62
BVpS1.78
TBVpS1.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.57%
ROE -4.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.51%
FCFM N/A
ROA(3y)-6.01%
ROA(5y)-3.16%
ROE(3y)-39.43%
ROE(5y)-22.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y4.47%
F-Score4
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 3.08
Debt/FCF N/A
Debt/EBITDA 11.88
Cap/Depr 23.58%
Cap/Sales 0.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 0.87
Altman-Z 0.56
F-Score4
WACC6.81%
ROIC/WACCN/A
Cap/Depr(3y)41.73%
Cap/Depr(5y)35.72%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.36%
Revenue growth 3Y3.27%
Revenue growth 5Y-7.36%
Sales Q2Q%-4.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y98.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.38%
FCF growth 3Y-48.2%
FCF growth 5Y9.11%
OCF growth 1Y86.8%
OCF growth 3Y-42.18%
OCF growth 5Y-12.51%